Follow
Camille Malouf, PhD
Camille Malouf, PhD
Research associate, IRCM
Verified email at ircm.qc.ca
Title
Cited by
Cited by
Year
The peptidomimetic CXCR4 antagonist TC14012 recruits β-arrestin to CXCR7: Roles of receptor domains
S Gravel, C Malouf, PE Boulais, YA Berchiche, S Oishi, N Fujii, R Leduc, ...
Journal of Biological Chemistry 285 (49), 37939-37943, 2010
1002010
Molecular processes involved in B cell acute lymphoblastic leukaemia
C Malouf, K Ottersbach
Cellular and molecular life sciences 75, 417-446, 2018
912018
Mll-AF4 confers enhanced self-renewal and lymphoid potential during a restricted window in development
NA Barrett, C Malouf, C Kapeni, WA Bacon, G Giotopoulos, ...
Cell reports 16 (4), 1039-1054, 2016
482016
miR-130b and miR-128a are essential lineage-specific codrivers of t (4; 11) MLL-AF4 acute leukemia
C Malouf, ETB Antunes, M O’Dwyer, H Jakobczyk, F Sahm, SL Landua, ...
Blood, The Journal of the American Society of Hematology 138 (21), 2066-2092, 2021
252021
The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of t (4; 11) MLL-AF4 infant leukemia
C Malouf, K Ottersbach
Haematologica 103 (12), e571, 2018
252018
DNA damage signalling from the placenta to foetal blood as a potential mechanism for childhood leukaemia initiation
E Mansell, N Zareian, C Malouf, C Kapeni, N Brown, C Badie, D Baird, ...
Scientific Reports 9 (1), 4370, 2019
122019
Defining the fetal origin of MLL-AF4 infant leukemia highlights specific fatty acid requirements
V Symeonidou, H Jakobczyk, S Bashanfer, C Malouf, F Fotopoulou, ...
Cell reports 37 (4), 2021
102021
Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly (I: C), but not to a single maternal immune activation
C Malouf, K Ottersbach
Experimental hematology 76, 49-59, 2019
52019
Translational research for bone marrow failure patients
C Malouf, SJ Loughran, AC Wilkinson, A Shimamura, P Río
Experimental hematology 105, 18-21, 2022
32022
Chronic inflammation can transform the fate of normal and mutant haematopoietic stem cells
J Li, C Malouf, LA Miles, MB Willis, EM Pietras, KY King
Experimental Hematology, 2023
22023
p57Kip2 regulates embryonic blood stem cells by controlling sympathoadrenal progenitor expansion
C Kapeni, L Nitsche, AM Kilpatrick, NK Wilson, K Xia, ...
Blood, The Journal of the American Society of Hematology 140 (5), 464-477, 2022
22022
Novel transcriptional targets of ETV6, a transcription factor frequently altered in childhood pre-B acute lymphoblastic leukemia
C Malouf, K Lagace, C Drullion, S Langlois, J Larose, EA Kritikou, ...
Cancer Sci Open Res Access 3 (1), 1-11, 2016
12016
The unconventional embryo: immune-restricted potential precedes multipotentiality
C Malouf, K Ottersbach
Cell Stem Cell 13 (5), 509-510, 2013
12013
Leukaemia in the CNS niche regulates PI3K/Akt signalling via upregulation of miR-93 in MLL-AF4+ infant leukaemia
A Duguid, C Malouf, C Halsey, K Ottersbach
Klinische Pädiatrie 235 (03), 193-194, 2023
2023
Exploiting somatic mutations to decipher human blood production: a natural lineage-tracing strategy
M Bloom, C Malouf, A Rodriguez-Fraticelli, AC Wilkinson, VG Sankaran, ...
Experimental Hematology, 2023
2023
A microRNA expression signature in infant t (4; 11) MLL-AF4+ BCP-ALL uncovers novel therapeutic targets
C Malouf, A Duguid, G Camiolo, L Nitsche, H Jakobczyk, RS Kotecha, ...
bioRxiv, 2023.01. 12.523775, 2023
2023
Leukaemia and the CNS Niche: Insights on Bidirectional Communication from a Model of Infant Leukaemia
A Duguid, C Malouf, V Symeonidou, C Halsey, K Ottersbach
Blood 140 (Supplement 1), 3038-3039, 2022
2022
Novel therapeutic avenues for MLL-AF4+ pro-B ALL patients based on a unique microRNA expression signature
C Malouf, A Duguid, K Ottersbach
Klinische Pädiatrie 234 (03), 175-175, 2022
2022
3105–IMPACT OF DACH1 DOWNREGULATION ON MLL-AF4 INFANT LEUKEMOGENESIS
H Jakobczyk, G Camiolo, C Malouf, E Antunes, K Ottersbach
Experimental Hematology 111, S97, 2022
2022
3008–EXPLOITING THE UNIQUE MICRORNA EXPRESSION SIGNATURE OF MLL-AF4+ PRO-B ALL FOR NOVEL THERAPEUTIC AVENUES
C Malouf, A Duguid, C Halsey, K Ottersbach
Experimental Hematology 111, S48, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–20